BHVN (biohavenpharma.com) Company Net Income

Official company branding of biohavenpharma.com (BHVN)

Biohaven Ltd. (BHVN) relies on US research centers while outsourcing drug manufacturing to external contractors. Market fluctuations in the share price visualize this process, where profit amounts to -0.59. Biohaven Ltd. (BHVN) specializes in therapies for neurodegenerative pathologies and migraines, maintaining a loyal audience. Supply efficiency is supported by flexible route management and an advanced drug distribution network.

BHVN Biohaven Company Net Income (07/04/2022 - 10/29/2026)

Financial and market metric breakdowns for Biohaven (BHVN)

- stock value and consensus price forecast:
Market Price Biohaven Corp|BHVN - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Biohaven Corp|BHVN - Enterprise Value
- book capitalization indicators:
Net Assets per Share Biohaven|BHVN - Company Book Value|Market-to-Book Ratio biohavenpharma.com|BHVN - Company Total Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Biohaven Ltd.|BHVN - Long-Term Debt to Capital|Short-Term Debt to Capital Biohaven Ltd|BHVN - Company Total Debt|Debt to Book Capitalization Ratio Biohaven Corp|BHVN - Company Long-Term Debts|Short-Term Debt Biohaven|Immediate Liquidity Ratio biohavenpharma.com
- earnings and multiples data:
BHVN - Net Income
Summary company analysis:Biohaven Corp, BHVN
Manufactured products of Biohaven

Biohaven Ltd. (BHVN) developments in targeted neuropreparations directly drive the company's profit dynamics. This metric captures the net financial result daily, turning financial reporting into a continuous business chronometer. The indicator measures the actual efficiency of operating activities, allowing speculative price fluctuations to be decoupled from fundamental growth. Strong pricing power in an inelastic pharmaceutical market ensures the stability of this figure. It is critical for investors to avoid purchasing an overvalued asset during sharp local peaks.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Company Net Income RGC|Net Profit AXSM|Net Financial Result ACADIA Pharma|Company Net Income Xenon Pharmaceuticals Inc XENE|Viking Therapeutics Corp (VKTX) - Company Net Income|Supernus Pharmaceuticals - Net Profit|Final Profit CPRX (catalystpharma.com)|DNLI: Net Profit|Harmony Biosciences Inc (HRMY) - Net Profit|Net Income AMLX|Company Net Income TRVI|Net Profit PRAX|AVXL - Company Net Income|Company Net Income CeriBell CBLL|PRTA: Company Profit|ALEC: Net Income|Final Profit ANNX (Annexon Biosciences Inc.)|omeros.com (OMER) - Company Net Income|NGNE (neurogene.com) - Company Net Income|Net Income ACIU|VYGR (Voyager Therapeutics Inc) - Profit After Payment of Taxes|Net Profit NMRA|Scilex Holding Company, Inc. - Company Profit|Tevogen Bio Holdings - Net Income|Net Financial Result Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Net Profit|IKT: Company Net Income|SAVA: Net Profit|Assertio - Final Profit|Net Income COYA|Company Net Income VTGN|Company Net Income Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals Inc. - Company Profit|Company Net Income CervoMed Inc CRVO|ATHE: Company Profit|Clene Nanomedicine - Net Profit|Company Net Income PepGen Inc.|JUNS (Jupiter Neurosciences Inc) - Net Income|Relmada Therapeutics Inc (RLMD) - Net Profit|Company Net Income Annovis Bio Corp|GRCE: Final Profit|Company Net Income Firefly Neuroscience, Inc (AIFF)|KLTO - Company Net Income|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|Reviva Pharmaceuticals Holdings Inc. - Company Net Income|MetaVia, Inc. - Net Profit|Net Financial Result NeurAxis Inc NRXS|heliusmedical.com (HSDT) - Company Net Income|Company Net Income Passage Bio (PASG)|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|NERV: Final Profit|Net Profit ATHA|Net Profit Addex (ADXN)|Alzamend Neuro - Net Income|Cyclerion Therapeutics Inc. - Company Net Income|Protagenic - Net Profit|Company Net Income Pasithea Therapeutics|cortigent.com (CRGT) - Company Net Income|Company Profit ATXI|Net Income BCLI|CARA: Final Profit|Company Net Income Chromocell Therapeutics Corp. (CHRO)|Company Net Income ELYM (eliemtx.com)|Intra-Cellular Therapies, Inc. - Net Income|Profit After Payment of Taxes LBPH (Longboard)|Marinus Pharmaceuticals - Net Profit|NKGN (nkgenbiotech.com) - Company Profit|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|SAGE - Net Financial Result|SNPX (Neurotrope) - Net Profit|Company Net Income TRVN|Net Profit VIGL|WENA (Anew Medical Inc.) - Final Profit|Cerevel Therapeutics, Inc. - Net Income